Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!
If you are interested in the 2025 event, please get in touch at info@hansonwade.com
Welcome to the 9th CAR-TCR Summit!
Were you and your team focusing on manufacturing efficiency, solid tumor durability, accessibility, safety, cost-efficiency, product release times, autoimmune indications, armoring, potency assays, resistance or investment for your cell therapy pipelines this year?
The 9th CAR-TCR Summit agenda had been created in collaboration with the cell therapy industry, for the cell therapy industry to address common challenges like these and many more. If you wanted to discuss these topics with like-minded industry experts and leading academics, then this was the only meeting you needed to attend in 2024.
Attendees gained in-depth insights that were specific to their functional role, whether their focus was on Discovery, Translation, Clinical Development, Early-Stage Manufacturing, Late-Stage Manufacturing, Analytical Development or Supply Chain & Clinical Operations.
Plus, attendees enjoyed improved networking opportunities, new bonus days, reduced rates, drinks receptions, scientific poster sessions and more.
With recent expanded approvals for BMS’s Breyanzi and Johnson & Johnson’s Carvykti and further approvals set for this year, attendees joined this industry at a pivotal time to celebrate the successes and overcome challenges together to deliver more curative treatments to the ever-growing population of patients in need.
View the Full 2024 Agenda to see the speaker faculty, what was new for 2024, full session details, who attendees met and much more!
Your Complete Guide to the 2024 Meeting is Here:
Full Cell Therapy Landscape
No matter which function, stage of development or approach attendees were working on, they met like-minded peers to workshop their common challenges
150+
Expert Speakers
Attendees learned from pioneering academics, innovative biotechs and heavyweight pharma and gained actionable insights to apply to their work
9+
Hours of Networking
Attendees met peers, investors, solution providers, and old and new friends across structured sessions, drinks receptions, private lunches, 1-1 meetings and more
7
Refined Tracks
For attendees working in Discovery, Translation, Clinical Development, Early- or Late-Stage Manufacturing, Analytical Development or Supply Chain & Clin Ops.
5
Bonus Days
Attendees took this extra opportunity to deep dive into autoimmune indications, solid tumors, investment, automation and fundamentals
David Sourdive
Co-Founder & Executive Vice President, CMC & Manufacturing
“The summit is a privileged meeting to assess the status, trends, challenges and opportunities in our field, as well as to interact with peers and technology/solution providers... We’re looking forward to the 2024 edition which will shed light on the broadening of CAR-T applicability”
150+ Drug Developer Companies Signed Up in 2024 Which Included:
2024 Expert Speakers Included:
Arun Pores Fernando
Director, Business Development, Search & Evaluation, Cell Therapy
Bristol Myers Squibb
Carl June
Richard W. Vague Professor in Immunotherapy, Director, Center for Cellular Immunotherapies
University of Pennsylvania
Arun Pores Fernando
Director, Business Development, Search & Evaluation, Cell Therapy
“The 9th CAR-TCR Summit provides a great opportunity to stay up to date on the recent advancements in the ever-expanding Cell therapy space. Looking forward to learning, networking, and sharing insights”
2024 Lead Partner
2024 Expertise Partners
Justin McCue
Chief Technology Officer
“The 9th CAR-TCR Summit provides forums for industry leaders, scientists and related experts in CAR/TCR technology and product development to interact and discuss this fast moving and highly complex field.”